Gradient Investments’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
WBG
HF
NCM
Gradient Investments's XPH Position: Q2 2015 in Review
Gradient Investments sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2015, closing a stake of 370 shares — an estimated $23K sold.
Gradient Investments first reported a position in XPH in Q2 2013 and held it in 2 quarters. The position peaked at $23K in Q1 2015. 85 funds tracked by Wall St. Rank hold XPH as of Q2 2015.
- Gradient Investments reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2015 after selling out during the quarter.
- Gradient Investments sold 370 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2015, an estimated $23K.
- Gradient Investments first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 2 quarters.
- Gradient Investments's State Street SPDR S&P Pharmaceuticals ETF position peaked at $23K in Q1 2015.
- 85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2015.
Based on Gradient Investments's 13F filing for Q2 2015, filed 25 Aug 2015.